• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    More On 009420.KS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    HanAll Biopharma Co., Ltd. (009420.KS)

    -KSC
    12,850.00 Down 100.00(0.77%) Feb 5, 1:00AM EST
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
    Net Income (2,663,000) (36,000) 321,000   (13,672,000)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation591,000  572,000  574,000  573,000  
    Adjustments To Net Income -   -   -   -  
    Changes In Accounts Receivables2,224,000  85,000  131,000  (157,000)
    Changes In Liabilities -   -   -   -  
    Changes In Inventories(2,428,000)(569,000)2,223,000  (2,686,000)
    Changes In Other Operating Activities1,240,000  (700,000)(131,000)(1,826,000)
    Total Cash Flow From Operating Activities (826,000) 895,000   735,000   324,000  
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(214,000)(1,174,000)(273,000)(174,000)
    Investments -   -   -   -  
    Other Cash flows from Investing Activities -   -   -   -  
    Total Cash Flows From Investing Activities (596,000) (450,000) 627,000   (2,078,000)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock -   -   -   -  
    Net Borrowings -   -   -   -  
    Other Cash Flows from Financing Activities(382,000)724,000  900,000  (1,904,000)
    Total Cash Flows From Financing Activities 39,306,000   (836,000) 6,000   1,477,000  
    Effect Of Exchange Rate Changes11,000  24,000  (20,000)15,000  
    Change In Cash and Cash Equivalents 37,394,000   (366,000) 1,348,000   (262,000)

    Currency in KRW.